Jonathan A. Tobert

10.8k citations
76 papers · 8.7k · 8 hit papers · h-index 35

Impact in

  • Surgery top 0.2%
    • Lipoproteins and Cardiovascular Health
    • Cholesterol and Lipid Metabolism
    • Peripheral Artery Disease Management
  • Nephrology top 0.5%
    • Chronic Kidney Disease and Diabetes
    • Dialysis and Renal Disease Management

Papers in

    • Lipoproteins and Cardiovascular Health 58
    • Gout, Hyperuricemia, Uric Acid 3
    • Chronic Kidney Disease and Diabetes 3

Jonathan A. Tobert

75 papers receiving 7.9k citations

Jonathan A. Tobert's Hit Papers

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis 2024 · 104 citations
1040+9+18Years since publication5001k1.5k

Peers

Jonathan A. Tobert
Comparison fields: 5 of 138
  • Surgery 5k
  • Nephrology 1.1k
  • Pharmacology 309
  • Cardiology and Cardiovascular Medicine 617
  • Geriatrics and Gerontology 90
Replace Jane Armitage with:
Jane Armitage United Kingdom
Alexandros D. Tselepis Greece
Christopher J. Packard United Kingdom
Anthony S. Wierzbicki United Kingdom
Michael B. Clearfield United States
Alberto Corsini Italy
José Tuñón Spain
Michel Farnier France
Michal Vrablı́k Czechia
Evangelos N. Liberopoulos Greece
Jonathan A. Tobert relative to Jane Armitage United Kingdom Jane Armitage's profile →
Citations per field
00.5×1.5×
Jane Armitage · 1×
Citations per year

Countries citing papers authored by Jonathan A. Tobert

Since Specialization
Citations

This map shows the geographic impact of Jonathan A. Tobert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan A. Tobert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan A. Tobert more than expected).

Fields of papers citing papers by Jonathan A. Tobert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan A. Tobert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan A. Tobert. The network helps show where Jonathan A. Tobert may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan A. Tobert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan A. Tobert Line = papers co-authored together Jonathan A. Tobert links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Hit paper breakdown →
20111952
2
Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors
Hit paper breakdown →
2003691
3
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
Hit paper breakdown →
2019607
4
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
Hit paper breakdown →
2013567
5
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
Hit paper breakdown →
2019565
6
Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)
Hit paper breakdown →
1998501
7 1998367
8 1988292
9 1993228
10
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials
Hit paper breakdown →
2022182
11 1982180
12 1987177
13 1997154
14 2014151
15 1984148
16 2004115
17 1999112
18 1999111
19 2016104
20
Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis
Hit paper breakdown →
2024104

About Jonathan A. Tobert

Jonathan A. Tobert is a scholar working on Surgery, Nephrology, Pharmacology, Immunology and Public Health, Environmental and Occupational Health, having authored 76 papers that have together received 8.7k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (58 papers), Gout, Hyperuricemia, Uric Acid (3 papers), Reproductive Health and Contraception (3 papers), Chronic Kidney Disease and Diabetes (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Reproductive System and Pregnancy (3 papers), Estrogen and related hormone effects (2 papers) and Drug Solubulity and Delivery Systems (1 paper). The work is most often cited by research in Surgery (5k citations), Nephrology (1.1k citations), Pharmacology (309 citations), Cardiology and Cardiovascular Medicine (617 citations) and Geriatrics and Gerontology (90 citations). Jonathan A. Tobert has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Terje Rolf Pedersen, Connie B. Newman, JOHN K. KJEKSHUS, Thomas J. Cook, ANDERS G. OLSSON, Torben Helge Haghfelt, Kalevi Pyörälà, David Preiss, Michele F. Mercuri and Eliot A. Brinton. Their work appears in journals such as The American Journal of Cardiology, The Lancet, Clinical Pharmacology & Therapeutics, JAMA and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact